19-14028385-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080864.4(RLN3):c.181G>A(p.Glu61Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000869 in 1,610,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080864.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RLN3 | NM_080864.4 | c.181G>A | p.Glu61Lys | missense_variant | 1/2 | ENST00000431365.3 | |
RLN3 | NM_001311197.2 | c.181G>A | p.Glu61Lys | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RLN3 | ENST00000431365.3 | c.181G>A | p.Glu61Lys | missense_variant | 1/2 | 1 | NM_080864.4 | P1 | |
RLN3 | ENST00000585987.1 | c.181G>A | p.Glu61Lys | missense_variant | 1/3 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 246062Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133070
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1458170Hom.: 0 Cov.: 32 AF XY: 0.00000827 AC XY: 6AN XY: 725278
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152252Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.181G>A (p.E61K) alteration is located in exon 1 (coding exon 1) of the RLN3 gene. This alteration results from a G to A substitution at nucleotide position 181, causing the glutamic acid (E) at amino acid position 61 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at